Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Praxis Pharmaceutical, S.A.

Latest From Praxis Pharmaceutical, S.A.

Deal Watch: Allergan Keeps After Hair Loss With Exicure Deal

Allergan has tried to go after alopecia in the past; Exicure brings a new spherical nucleic acid (SNA) technology. In other recent deals, AstraZeneca sells Seroquel, Losec rights to Germany’s Cheplapharm.

Deals Business Strategies

Acumen raises $20m Series A for Alzheimer's antibody

Acumen Pharmaceuticals completed the first closing a $20 million Series A funding round, which will be used to demonstrate proof of concept for the monoclonal antibody ACU-193 in the treatment of Alzheimer's disease by 2016.


STOCKWATCH: And they will come in the emperor’s new clothes

Metabolic Disorders Cancer

Patient fees in Estonia to rise next year

As the budget of Estonia's health insurance fund, the Haigekassa, is to be cut by 6% next year, patient fees for hospital stays are to be increased to Eek100 ($9.40) per day from the beginning of next year. At present, they are Eek25 per day during the first 10 days in hospital, and children and teenagers under 19 years of age, pregnant women and patients in intensive care wards are exempt.

See All

Company Information

  • Industry
  • Contract Manufacturing Organization
  • Other Names / Subsidiaries
    • PRX Pharma Produtos Farmacêuticos Unipessoal, LDA